Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Novavax FY EPS $(5.41) Up From $(8.42) YoY, Sales $983.71M Down From $1.98B YoY

Author: Benzinga Newsdesk | February 28, 2024 08:51am
Novavax (NASDAQ:NVAX) reported quarterly losses of $(5.41) per share. This is a 35.75 percent increase over losses of $(8.42) per share from the same period last year. The company reported $983.71 million in sales this quarter. This is a 50.36 percent decrease over sales of $1.98 billion the same period last year.

Posted In: NVAX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist